 emboli infect endocard prognost valu echocardiographi object veget two-dimension echocardiographi independ risk factor develop subsequ emboli patient infect endocard time emboli rel initi antimicrobi therapi design investigator-blind retrospect incid cohort studi set tertiari referr center patient patient left-sid nativ valv infect endocard two-dimension echocardiographi hour antimicrobi therapi measur main result crude incid rate first embol event patient antimicrobi therapi patient-day CI rate patient veget patient-day incid rate ratio CI relat veget risk emboli microorganism-depend stratifi incid rate ratio CI CI viridan streptococc staphylococcu endocard rate first embol event time patient-day first week therapi patient-day complet second week therapi conclus overal presenc veget echocardiographi risk embolu patient left-sid nativ valv infect endocard rel risk embol event veget microorganism-depend risk patient viridan streptococc infect rate embol event declin time initi antimicrobi treatment